معرفی
Yajaira Suarez is the Anthony N. Brady Professor of Comparative Medicine and Pathology at Yale School of Medicine, where she also serves as Deputy Chair of the Department of Comparative Medicine. She holds secondary appointments in Pathology and is affiliated with multiple interdisciplinary research centers, including the Yale Cancer Center, Vascular Biology and Therapeutics Program, Yale Center for Molecular and Systems Metabolism (YMSM), and the Center for RNA Science and Medicine.
- PhD, Universidad Autónoma de Madrid (2001)
- BS, Universidad Autónoma de Madrid (1995)
- Postdoctoral Training, Consejo Superior de Investigaciones Científicas (CSIC)-Universidad Autónoma de Madrid
- Postdoctoral Training, Yale University School of Medicine
Her research focuses on endothelial cell and macrophage biology, particularly the interplay between angiogenesis, inflammation, and metabolism in diseases such as atherosclerosis, cancer, and metabolic disorders. She investigates the role of non-coding RNAs, metabolic rewiring, immunometabolism, and cholesterol regulation in vascular and inflammatory pathologies.
Her recent publications reveal a strong trend in endothelial and macrophage metabolism, lipid signaling, and non-coding RNA regulation in vascular and liver diseases. Key themes include the protective role of endothelial triglyceride metabolism, metabolic reprogramming in angiogenesis, and miR-33’s role in liver and neuronal regulation. These works span top journals such as Nature Communications, Journal of Clinical Investigation, and Circulation.
Notable scientific awards include:
- 2025 Recipient of the Judah Folkman Award in Vascular Biology
- Elected member of the Connecticut Academy of Science and Engineering (2022)
- Werner Risau New Investigator Award in Vascular Biology
- Kingsley Award in Medical Research (Yale)
- CNIC P3+3 Postdoctoral Fellowship (Spain)
Dr. Suarez has secured significant research funding and leads a vibrant laboratory collaborating with prominent scientists such as Carlos Fernandez-Hernando, Jordan Pober, and Bill Sessa. She mentors numerous postdoctoral fellows and graduate students and is actively involved in training programs like the Yale Combined Program in the Biological and Biomedical Sciences (BBS). Her work bridges basic science with translational applications in cardiometabolic and vascular diseases.
She leads research initiatives within the Vascular Biology and Therapeutics Program and collaborates extensively through centers such as the Diabetes Research Center and the Cancer Signaling Networks. Her lab utilizes genetically modified mouse models and molecular techniques to dissect regulatory mechanisms in vascular and metabolic diseases.
